the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in Oral Lichen Planus Patients
NCT05400057 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-10-10
Summary
Assessment The oncogenic potential of salivary microRNA-93 and microRNA-412-3p in oral lichen planus
Conditions
- Oral Lichen Planus
- Oral Cancer
Sponsors & Collaborators
-
Cairo University
collaborator OTHER -
Moataz Mahmoud
lead OTHER
Principal Investigators
-
Moataz Taha, PhD student · Faculty of Dentistry, CairoU
-
Weam Rashwan, Professor · Faculty of Dentistry, CairoU
-
Olfat Shaker, Professor · Faculty of Medicine, CairoU
-
Inas Abdou, Lecturer · Center Of Radiation Oncology & Nuclear Medicine, CairoU
Eligibility
- Min Age
- 40 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-15
- Primary Completion
- 2023-09-20
- Completion
- 2023-09-30
Countries
- Egypt
Study Locations
More Related Trials
-
Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring
NCT06469892 ·Status: COMPLETED
-
Cathelicidin LL-37 Relation to Potentially Malignant Lesions
NCT06219330 ·Status: COMPLETED
-
Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity
NCT01636544 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Levels of Salivary Paxillin Oral Premalignant and Malignant Lesions
NCT06154551 ·Status: COMPLETED
-
Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line
NCT03292822 ·Status: COMPLETED ·Phase: PHASE1
-
Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study
NCT06031337 ·Status: COMPLETED
-
Effect of Cannabis and Cigarette Smoking on Oral Mucosa
NCT03334279 ·Status: UNKNOWN
-
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
NCT06876038 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
The Role of microRNA-29b in the Oral Squamous Cell Carcinoma
NCT02009852 ·Status: UNKNOWN
-
Validation of Salivary Proteomic Biomarkers for Early Detection of Oral Cancer in Egyptian Population
NCT06471270 ·Status: COMPLETED ·Phase: NA
-
Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions
NCT04732741 ·Status: UNKNOWN
-
The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients
NCT05023863 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Evaluating Treatment Strategies for p53 Mutant Oral Cancer and Oral Cancer Precursors
NCT07090070 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis
NCT02401763 ·Status: UNKNOWN
-
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
NCT05966194 ·Status: RECRUITING ·Phase: PHASE2
-
Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas
NCT03687294 ·Status: UNKNOWN
-
Efficacy of EGF-loaded Self Healing Gel in Treatment of Oral Mucositis
NCT04995354 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions
NCT05536037 ·Status: TERMINATED ·Phase: PHASE1
-
8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions
NCT03830710 ·Status: COMPLETED
-
Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma
NCT01987934 ·Status: UNKNOWN
-
Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions
NCT00507182 ·Status: COMPLETED ·Phase: NA
-
Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore
NCT03975322 ·Status: RECRUITING
-
A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy
NCT00540332 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
NCT02581137 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Least Invasive Nonlinear Light Microscopy
NCT00767442 ·Status: UNKNOWN